Generation Bio Co. (GBIO) NASDAQ

$17.38 0.06 (0.35%)

Market Cap: $985.68M

As of 11/30/21 11:17 AM EST. Market open.

(GBIO)

Generation Bio Co. (GBIO) NASDAQ

$17.38 0.06 (0.35%)

Market Cap: $985.68M

As of 11/30/21 11:17 AM EST. Market open.

Generation Bio is an innovative genetic medicines company focused on creating a new class of non-viral gene therapy to provide durable, redosable treatments for people living with rare and prevalent diseases. The company's non-viral platform incorporates a proprietary, high-capacity DNA construct called closed-ended DNA, or ceDNA; a cell-targeted lipid nanoparticle delivery system, or ctLNP; and ... read more

Generation Bio is an innovative genetic medicines company focused on creating a new class of non-viral gene therapy to provide durable, redosable treatments for people living with rare and prevalent diseases. The company's non-viral platform incorporates a proprietary, high-capacity DNA construct called closed-ended DNA, or ceDNA; a cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The platform is designed to enable multi-year durability from a single dose of ceDNA and to allow titration and redosing if needed. The ctLNP is engineered to deliver large genetic payloads, including multiple genes, to specific tissues to address a wide range of indications. The company's efficient, scalable manufacturing process supports Generation Bio's mission to extend the reach of gene therapy to more people, living with more diseases, in more places around the world. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
100
Address
.
KEY STATS
Open
$17.38
Previous Close
$17.32
Days Range
$17.23 - $19.55
52 week range
$17.01 - $55.72
Volume
38,453
Avg. Volume (30 days)
166,080
Market Cap
$985.68M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
56,909,764
Open
$17.38
Previous Close
$17.32
Days Range
$17.23 - $19.55
52 week range
$17.01 - $55.72
Volume
38,453
Avg. Volume (30 days)
166,080
Market Cap
$985.68M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
56,909,764

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR GENERATION BIO CO
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Rhodes Jason P Director Sep 27, 2021 Sale $25.70 51,389 1,320,697 29,645 Sep 29, 2021, 07:16 PM
Rhodes Jason P Director Sep 29, 2021 Sale $24.59 16,586 407,850 608 Sep 29, 2021, 07:16 PM
Rhodes Jason P Director Sep 28, 2021 Sale $25.24 13,113 330,972 16,556 Sep 29, 2021, 07:16 PM
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner Sep 28, 2021 Sale $25.24 13,089 330,366 16,556 Sep 29, 2021, 07:15 PM
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner Sep 27, 2021 Sale $25.70 95 2,442 662 Sep 29, 2021, 07:15 PM
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner Sep 29, 2021 Sale $24.59 30 738 608 Sep 29, 2021, 07:15 PM
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner Sep 27, 2021 Sale $25.70 51,294 1,318,256 29,645 Sep 29, 2021, 07:15 PM
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner Sep 29, 2021 Sale $24.59 16,556 407,112 0 Sep 29, 2021, 07:15 PM
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner Sep 28, 2021 Sale $25.24 24 606 638 Sep 29, 2021, 07:15 PM
Rhodes Jason P Director Sep 23, 2021 Sale $26.13 75,465 1,972,127 109,802 Sep 24, 2021, 09:02 PM
Rhodes Jason P Director Sep 22, 2021 Sale $25.89 30,617 792,705 185,126 Sep 24, 2021, 09:02 PM
Rhodes Jason P Director Sep 24, 2021 Sale $25.84 28,916 747,161 80,939 Sep 24, 2021, 09:02 PM
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner Sep 22, 2021 Sale $25.89 57 1,476 951 Sep 24, 2021, 08:59 PM
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner Sep 24, 2021 Sale $25.84 28,862 745,765 80,939 Sep 24, 2021, 08:59 PM
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner Sep 23, 2021 Sale $26.13 75,325 1,968,469 109,802 Sep 24, 2021, 08:59 PM
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner Sep 24, 2021 Sale $25.84 54 1,395 757 Sep 24, 2021, 08:59 PM
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner Sep 22, 2021 Sale $25.89 30,560 791,229 185,126 Sep 24, 2021, 08:59 PM
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner Sep 23, 2021 Sale $26.13 140 3,659 811 Sep 24, 2021, 08:59 PM
Stanton Matthew CHIEF SCIENTIFIC OFFICER Sep 14, 2021 Option Exercise $4.59 4,500 20,655 202,654 Sep 16, 2021, 04:12 PM
Stanton Matthew CHIEF SCIENTIFIC OFFICER Sep 14, 2021 Sale $28.07 4,500 126,315 198,154 Sep 16, 2021, 04:12 PM
Stanton Matthew CHIEF SCIENTIFIC OFFICER Sep 10, 2021 Option Exercise $4.59 3,000 13,770 201,154 Sep 14, 2021, 04:02 PM
Stanton Matthew CHIEF SCIENTIFIC OFFICER Sep 10, 2021 Sale $25.97 3,000 77,910 198,954 Sep 14, 2021, 04:02 PM
Stanton Matthew CHIEF SCIENTIFIC OFFICER Aug 23, 2021 Option Exercise $4.59 1,500 6,885 199,654 Aug 25, 2021, 04:05 PM
Stanton Matthew CHIEF SCIENTIFIC OFFICER Aug 23, 2021 Sale $25.04 1,500 37,560 198,154 Aug 25, 2021, 04:05 PM
Stanton Matthew CHIEF SCIENTIFIC OFFICER Aug 10, 2021 Option Exercise $4.59 1,500 6,885 199,654 Aug 11, 2021, 04:20 PM
Stanton Matthew CHIEF SCIENTIFIC OFFICER Aug 10, 2021 Sale $22.63 1,500 33,943 198,654 Aug 11, 2021, 04:20 PM
Stanton Matthew CHIEF SCIENTIFIC OFFICER Jul 12, 2021 Option Exercise $4.59 3,000 13,770 201,154 Jul 14, 2021, 04:02 PM
Stanton Matthew CHIEF SCIENTIFIC OFFICER Jul 12, 2021 Sale $25.03 3,000 75,087 199,854 Jul 14, 2021, 04:02 PM
Kerr Douglas CHIEF MEDICAL OFFICER Jul 08, 2021 Option Exercise $5.16 3,518 18,153 330,076 Jul 12, 2021, 04:02 PM
Kerr Douglas CHIEF MEDICAL OFFICER Jul 08, 2021 Sale $25.20 3,518 88,670 328,447 Jul 12, 2021, 04:02 PM
Rhodes Jason P Director Jun 24, 2021 Sale $25.85 31,008 801,618 4,092 Jun 28, 2021, 04:57 PM
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner Jun 24, 2021 Sale $25.86 58 1,500 616 Jun 28, 2021, 04:56 PM
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner Jun 24, 2021 Sale $25.85 30,950 800,119 4,092 Jun 28, 2021, 04:56 PM
Rhodes Jason P Director Jun 22, 2021 Sale $24.95 58,577 1,461,479 118,651 Jun 23, 2021, 08:27 PM
Rhodes Jason P Director Jun 21, 2021 Sale $24.84 63,892 1,586,940 155,708 Jun 23, 2021, 08:27 PM
Rhodes Jason P Director Jun 23, 2021 Sale $25.36 62,609 1,587,548 59,281 Jun 23, 2021, 08:27 PM
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner Jun 22, 2021 Sale $24.95 108 2,695 829 Jun 23, 2021, 08:26 PM
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner Jun 22, 2021 Sale $24.95 58,469 1,458,784 118,651 Jun 23, 2021, 08:26 PM
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner Jun 21, 2021 Sale $24.84 118 2,931 897 Jun 23, 2021, 08:26 PM
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner Jun 23, 2021 Sale $25.36 116 2,942 719 Jun 23, 2021, 08:26 PM
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner Jun 21, 2021 Sale $24.84 63,774 1,584,009 155,708 Jun 23, 2021, 08:26 PM
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner Jun 23, 2021 Sale $25.36 62,493 1,584,606 59,281 Jun 23, 2021, 08:26 PM
Stanton Matthew CHIEF SCIENTIFIC OFFICER May 27, 2021 Option Exercise $4.59 1,500 6,885 199,654 May 28, 2021, 04:05 PM
Stanton Matthew CHIEF SCIENTIFIC OFFICER May 27, 2021 Sale $34.05 1,500 51,075 198,154 May 28, 2021, 04:05 PM
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER Apr 22, 2021 Option Exercise $4.59 2,500 11,475 2,500 Apr 23, 2021, 04:05 PM
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER Apr 22, 2021 Sale $33.32 2,500 83,300 0 Apr 23, 2021, 04:05 PM
Stanton Matthew CHIEF SCIENTIFIC OFFICER Apr 21, 2021 Option Exercise $0.60 1,500 900 199,654 Apr 23, 2021, 04:05 PM
Stanton Matthew CHIEF SCIENTIFIC OFFICER Apr 22, 2021 Option Exercise $0.60 1,500 900 199,654 Apr 23, 2021, 04:05 PM
Stanton Matthew CHIEF SCIENTIFIC OFFICER Apr 21, 2021 Sale $31.07 1,500 46,605 198,154 Apr 23, 2021, 04:05 PM
Stanton Matthew CHIEF SCIENTIFIC OFFICER Apr 22, 2021 Sale $34.03 1,500 51,045 198,154 Apr 23, 2021, 04:05 PM
Stanton Matthew CHIEF SCIENTIFIC OFFICER Apr 16, 2021 Option Exercise $0.60 1,500 900 199,654 Apr 20, 2021, 04:05 PM
Stanton Matthew CHIEF SCIENTIFIC OFFICER Apr 16, 2021 Sale $28.03 1,500 42,045 198,154 Apr 20, 2021, 04:05 PM
Rhodes Jason P Director Apr 14, 2021 Sale $26.61 23,413 622,995 12,874 Apr 14, 2021, 08:20 PM
Rhodes Jason P Director Apr 13, 2021 Sale $25.16 43,145 1,085,744 30,767 Apr 14, 2021, 08:20 PM
Rhodes Jason P Director Apr 12, 2021 Sale $26.15 74,124 1,938,229 77,329 Apr 14, 2021, 08:20 PM
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner Apr 12, 2021 Sale $26.15 74,124 1,938,229 77,329 Apr 14, 2021, 08:19 PM
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner Apr 14, 2021 Sale $26.61 23,413 622,995 12,874 Apr 14, 2021, 08:19 PM
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner Apr 13, 2021 Sale $25.16 43,145 1,085,744 30,767 Apr 14, 2021, 08:19 PM
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner Apr 08, 2021 Sale $28.50 43,550 1,241,241 187,554 Apr 09, 2021, 08:54 PM
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner Apr 07, 2021 Sale $28.51 39,864 1,136,671 229,807 Apr 09, 2021, 08:54 PM
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner Apr 09, 2021 Sale $27.61 43,681 1,205,948 142,814 Apr 09, 2021, 08:54 PM
Rhodes Jason P Director Apr 09, 2021 Sale $27.61 43,681 1,205,948 142,814 Apr 09, 2021, 08:53 PM
Rhodes Jason P Director Apr 08, 2021 Sale $28.50 43,550 1,241,241 187,554 Apr 09, 2021, 08:53 PM
Rhodes Jason P Director Apr 07, 2021 Sale $28.51 39,864 1,136,671 229,807 Apr 09, 2021, 08:53 PM
Stanton Matthew CHIEF SCIENTIFIC OFFICER Mar 10, 2021 Option Exercise $0.60 10,500 6,300 208,654 Mar 12, 2021, 04:03 PM
Stanton Matthew CHIEF SCIENTIFIC OFFICER Mar 10, 2021 Sale $34.97 10,500 367,209 204,104 Mar 12, 2021, 04:03 PM
Kerr Douglas CHIEF MEDICAL OFFICER Mar 05, 2021 Option Exercise $4.59 11,267 51,716 337,825 Mar 09, 2021, 04:05 PM
Kerr Douglas CHIEF MEDICAL OFFICER Mar 05, 2021 Sale $31.44 11,267 354,267 335,148 Mar 09, 2021, 04:05 PM
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER Mar 03, 2021 Option Exercise $4.59 3,000 13,770 3,000 Mar 05, 2021, 04:05 PM
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER Mar 03, 2021 Sale $41.38 3,000 124,140 0 Mar 05, 2021, 04:05 PM
MCDONOUGH GEOFF PRESIDENT AND CEO Mar 01, 2021 Sale $37.58 10,000 375,801 1,202,690 Mar 03, 2021, 04:10 PM
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER Mar 01, 2021 Option Exercise $4.59 2,500 11,475 2,500 Mar 03, 2021, 04:10 PM
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER Mar 01, 2021 Sale $38.84 2,500 97,099 2,300 Mar 03, 2021, 04:10 PM
Stanton Matthew CHIEF SCIENTIFIC OFFICER Feb 10, 2021 Option Exercise $0.60 10,400 6,240 208,554 Feb 12, 2021, 04:05 PM
Stanton Matthew CHIEF SCIENTIFIC OFFICER Feb 10, 2021 Sale $34.60 10,400 359,856 205,925 Feb 12, 2021, 04:05 PM
Kerr Douglas CHIEF MEDICAL OFFICER Feb 08, 2021 Option Exercise $4.59 11,267 51,716 337,825 Feb 10, 2021, 04:05 PM
Kerr Douglas CHIEF MEDICAL OFFICER Feb 08, 2021 Sale $33.37 11,267 375,954 330,325 Feb 10, 2021, 04:05 PM
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER Feb 02, 2021 Option Exercise $4.59 2,500 11,475 2,500 Feb 04, 2021, 04:05 PM
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER Feb 02, 2021 Sale $33.05 2,500 82,625 0 Feb 04, 2021, 04:05 PM
Angelino Mark D. CHIEF OPERATING OFFICER Jan 15, 2021 Option Exercise $4.59 7,500 34,425 353,137 Jan 20, 2021, 04:05 PM
Angelino Mark D. CHIEF OPERATING OFFICER Jan 15, 2021 Sale $32.97 7,500 247,273 349,637 Jan 20, 2021, 04:05 PM
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER Jan 14, 2021 Option Exercise $4.59 2,500 11,475 2,500 Jan 15, 2021, 04:06 PM
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER Jan 14, 2021 Sale $33.09 2,500 82,725 0 Jan 15, 2021, 04:06 PM
Stanton Matthew CHIEF SCIENTIFIC OFFICER Jan 14, 2021 Option Exercise $0.60 5,630 3,378 203,784 Jan 15, 2021, 04:05 PM
Stanton Matthew CHIEF SCIENTIFIC OFFICER Jan 14, 2021 Sale $32.54 5,630 183,212 200,944 Jan 15, 2021, 04:05 PM
Kerr Douglas CHIEF MEDICAL OFFICER Jan 11, 2021 Option Exercise $4.59 11,267 51,716 337,825 Jan 13, 2021, 04:07 PM
Kerr Douglas CHIEF MEDICAL OFFICER Jan 11, 2021 Sale $27.58 11,267 310,768 331,579 Jan 13, 2021, 04:07 PM
Stanton Matthew CHIEF SCIENTIFIC OFFICER Jan 11, 2021 Option Exercise $0.60 14,820 8,892 212,974 Jan 13, 2021, 04:06 PM
Stanton Matthew CHIEF SCIENTIFIC OFFICER Jan 11, 2021 Sale $27.69 14,820 410,372 206,705 Jan 13, 2021, 04:06 PM
Nicholson Donald William Director Jan 11, 2021 Buy $24.50 4,081 99,985 103,157 Jan 13, 2021, 04:05 PM
Rowland Charles A Jr Director Jan 11, 2021 Buy $24.50 20,408 499,996 101,035 Jan 13, 2021, 04:04 PM
Angelino Mark D. Chief Operating Officer Dec 15, 2020 Option Exercise $4.59 5,301 24,332 350,938 Dec 17, 2020, 04:05 PM
Angelino Mark D. Chief Operating Officer Dec 15, 2020 Sale $34.98 5,301 185,431 346,537 Dec 17, 2020, 04:05 PM
Stanton Matthew Chief Scientific Officer Dec 10, 2020 Option Exercise $0.60 10,540 6,324 208,694 Dec 14, 2020, 04:05 PM
Stanton Matthew Chief Scientific Officer Dec 10, 2020 Sale $37.62 10,540 396,499 203,376 Dec 14, 2020, 04:05 PM
Angelino Mark D. Chief Operating Officer Aug 14, 2020 Option Exercise $0.60 62,560 37,536 345,637 Aug 18, 2020, 04:07 PM
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner Jun 16, 2020 Buy $19.00 1,100,000 20,900,000 2,112,546 Jun 18, 2020, 06:02 PM
Invus Public Equities, L.P. 10% Owner Jun 16, 2020 Buy $19.00 800,000 15,200,000 2,814,191 Jun 18, 2020, 06:01 PM
Rowland Charles A Jr Director Jun 16, 2020 Buy $19.00 30,000 570,000 80,627 Jun 18, 2020, 05:30 PM
Casdin Capital, LLC 10% Owner Jun 16, 2020 Buy $19.00 650,000 12,350,000 1,611,215 Jun 18, 2020, 05:29 PM
Zone Healthcare Holdings, LLC 10% Owner Jun 16, 2020 Buy $19.00 400,000 7,600,000 1,918,819 Jun 17, 2020, 05:00 PM
Seybold William 10% Owner Jun 16, 2020 Buy $19.00 400,000 7,600,000 1,918,819 Jun 17, 2020, 04:59 PM
Flynn James E 10% Owner Jun 16, 2020 Buy $19.00 225,000 4,275,000 1,186,215 Jun 16, 2020, 02:50 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Rhodes Jason P Director 09/27/2021 1,320,697
Rhodes Jason P Director 09/29/2021 407,850
Rhodes Jason P Director 09/28/2021 330,972
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner 09/28/2021 330,366
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner 09/27/2021 2,442
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner 09/29/2021 738
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner 09/27/2021 1,318,256
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner 09/29/2021 407,112
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner 09/28/2021 606
Rhodes Jason P Director 09/23/2021 1,972,127
Rhodes Jason P Director 09/22/2021 792,705
Rhodes Jason P Director 09/24/2021 747,161
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner 09/22/2021 1,476
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner 09/24/2021 745,765
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner 09/23/2021 1,968,469
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner 09/24/2021 1,395
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner 09/22/2021 791,229
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner 09/23/2021 3,659
Stanton Matthew CHIEF SCIENTIFIC OFFICER 09/14/2021 20,655
Stanton Matthew CHIEF SCIENTIFIC OFFICER 09/14/2021 126,315
Stanton Matthew CHIEF SCIENTIFIC OFFICER 09/10/2021 13,770
Stanton Matthew CHIEF SCIENTIFIC OFFICER 09/10/2021 77,910
Stanton Matthew CHIEF SCIENTIFIC OFFICER 08/23/2021 6,885
Stanton Matthew CHIEF SCIENTIFIC OFFICER 08/23/2021 37,560
Stanton Matthew CHIEF SCIENTIFIC OFFICER 08/10/2021 6,885
Stanton Matthew CHIEF SCIENTIFIC OFFICER 08/10/2021 33,943
Stanton Matthew CHIEF SCIENTIFIC OFFICER 07/12/2021 13,770
Stanton Matthew CHIEF SCIENTIFIC OFFICER 07/12/2021 75,087
Kerr Douglas CHIEF MEDICAL OFFICER 07/08/2021 18,153
Kerr Douglas CHIEF MEDICAL OFFICER 07/08/2021 88,670
Rhodes Jason P Director 06/24/2021 801,618
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner 06/24/2021 1,500
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner 06/24/2021 800,119
Rhodes Jason P Director 06/22/2021 1,461,479
Rhodes Jason P Director 06/21/2021 1,586,940
Rhodes Jason P Director 06/23/2021 1,587,548
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner 06/22/2021 2,695
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner 06/22/2021 1,458,784
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner 06/21/2021 2,931
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner 06/23/2021 2,942
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner 06/21/2021 1,584,009
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner 06/23/2021 1,584,606
Stanton Matthew CHIEF SCIENTIFIC OFFICER 05/27/2021 6,885
Stanton Matthew CHIEF SCIENTIFIC OFFICER 05/27/2021 51,075
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER 04/22/2021 11,475
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER 04/22/2021 83,300
Stanton Matthew CHIEF SCIENTIFIC OFFICER 04/21/2021 900
Stanton Matthew CHIEF SCIENTIFIC OFFICER 04/22/2021 900
Stanton Matthew CHIEF SCIENTIFIC OFFICER 04/21/2021 46,605
Stanton Matthew CHIEF SCIENTIFIC OFFICER 04/22/2021 51,045
Stanton Matthew CHIEF SCIENTIFIC OFFICER 04/16/2021 900
Stanton Matthew CHIEF SCIENTIFIC OFFICER 04/16/2021 42,045
Rhodes Jason P Director 04/14/2021 622,995
Rhodes Jason P Director 04/13/2021 1,085,744
Rhodes Jason P Director 04/12/2021 1,938,229
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner 04/12/2021 1,938,229
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner 04/14/2021 622,995
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner 04/13/2021 1,085,744
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner 04/08/2021 1,241,241
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner 04/07/2021 1,136,671
ATLAS VENTURE ASSOCIATES X, L.P. 10% Owner 04/09/2021 1,205,948
Rhodes Jason P Director 04/09/2021 1,205,948
Rhodes Jason P Director 04/08/2021 1,241,241
Rhodes Jason P Director 04/07/2021 1,136,671
Stanton Matthew CHIEF SCIENTIFIC OFFICER 03/10/2021 6,300
Stanton Matthew CHIEF SCIENTIFIC OFFICER 03/10/2021 367,209
Kerr Douglas CHIEF MEDICAL OFFICER 03/05/2021 51,716
Kerr Douglas CHIEF MEDICAL OFFICER 03/05/2021 354,267
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER 03/03/2021 13,770
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER 03/03/2021 124,140
MCDONOUGH GEOFF PRESIDENT AND CEO 03/01/2021 375,801
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER 03/01/2021 11,475
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER 03/01/2021 97,099
Stanton Matthew CHIEF SCIENTIFIC OFFICER 02/10/2021 6,240
Stanton Matthew CHIEF SCIENTIFIC OFFICER 02/10/2021 359,856
Kerr Douglas CHIEF MEDICAL OFFICER 02/08/2021 51,716
Kerr Douglas CHIEF MEDICAL OFFICER 02/08/2021 375,954
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER 02/02/2021 11,475
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER 02/02/2021 82,625
Angelino Mark D. CHIEF OPERATING OFFICER 01/15/2021 34,425
Angelino Mark D. CHIEF OPERATING OFFICER 01/15/2021 247,273
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER 01/14/2021 11,475
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER 01/14/2021 82,725
Stanton Matthew CHIEF SCIENTIFIC OFFICER 01/14/2021 3,378
Stanton Matthew CHIEF SCIENTIFIC OFFICER 01/14/2021 183,212
Kerr Douglas CHIEF MEDICAL OFFICER 01/11/2021 51,716
Kerr Douglas CHIEF MEDICAL OFFICER 01/11/2021 310,768
Stanton Matthew CHIEF SCIENTIFIC OFFICER 01/11/2021 8,892
Stanton Matthew CHIEF SCIENTIFIC OFFICER 01/11/2021 410,372
Nicholson Donald William Director 01/11/2021 99,985
Rowland Charles A Jr Director 01/11/2021 499,996
Angelino Mark D. Chief Operating Officer 12/15/2020 24,332
Angelino Mark D. Chief Operating Officer 12/15/2020 185,431
Stanton Matthew Chief Scientific Officer 12/10/2020 6,324
Stanton Matthew Chief Scientific Officer 12/10/2020 396,499
Angelino Mark D. Chief Operating Officer 08/14/2020 37,536
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner 06/16/2020 20,900,000
Invus Public Equities, L.P. 10% Owner 06/16/2020 15,200,000
Rowland Charles A Jr Director 06/16/2020 570,000
Casdin Capital, LLC 10% Owner 06/16/2020 12,350,000
Zone Healthcare Holdings, LLC 10% Owner 06/16/2020 7,600,000
Seybold William 10% Owner 06/16/2020 7,600,000
Flynn James E 10% Owner 06/16/2020 4,275,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2021
06/30/2021
0.47%
1Q
09/30/2021
03/31/2021
1.34%
2Q

Period of Report: 09/30/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2021
0.47%
1Q
03/31/2021
1.34%
2Q